A Psychosocial Genomics Pilot Study in Oncology for Verifying Clinical, Inflammatory and Psychological Effects of Mind-Body Transformations-Therapy (MBT-T) in Breast Cancer Patients: Preliminary Results.

breast cancer cytokines inflammation mind-body transformations therapy (MBT-T)

Journal

Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588

Informations de publication

Date de publication:
03 Jan 2021
Historique:
received: 16 11 2020
revised: 26 12 2020
accepted: 30 12 2020
entrez: 6 1 2021
pubmed: 7 1 2021
medline: 7 1 2021
Statut: epublish

Résumé

Several studies have highlighted the key role of chronic inflammation in breast cancer development, progression, metastasis, and therapeutic outcome. These processes are mediated through a variety of cytokines and hormones that exert their biological actions either locally or distantly via systemic circulation. Recent findings suggest that positive psychosocial experiences, including psychotherapeutic interventions and therapeutic mind-body protocols, can modulate the inflammatory response by reducing the expression of genes/proteins associated with inflammation and stress-related pathways. Our preliminary results indicate that a specific mind-body therapy (MBT-T) could induce a significant reduction of the release of different cytokines and chemokines, such as SCGFβ, SDF-1α, MCP3, GROα, LIF, and IL-18, in the sera of breast cancer patients compared to a control group, suggesting that MBT-T could represent a promising approach to improve the wellness and outcome of breast cancer patients.

Identifiants

pubmed: 33401546
pii: jcm10010136
doi: 10.3390/jcm10010136
pmc: PMC7796278
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Nat Cell Biol. 2018 Sep;20(9):1084-1097
pubmed: 30154549
Breast Cancer. 2020 Sep 14;:
pubmed: 32929637
Behav Sci (Basel). 2020 Jul 30;10(8):
pubmed: 32751650
J Clin Invest. 2011 Oct;121(10):3786-8
pubmed: 21965334
Blood. 2008 Nov 1;112(9):3723-34
pubmed: 18694997
Am J Clin Hypn. 2004 Jan;46(3):215-27
pubmed: 15190727
Neurobiol Dis. 2010 Jul;39(1):73-84
pubmed: 20114075
J Clin Oncol. 2008 Aug 1;26(22):3660-2
pubmed: 18669447
Am J Clin Hypn. 2002 Oct;45(2):103-18
pubmed: 12382379
Pathobiology. 2015 Sep;82(3-4):142-52
pubmed: 26330355
Cell Immunol. 2011;270(1):80-7
pubmed: 21600570
Cell. 2011 Mar 4;144(5):646-74
pubmed: 21376230
PLoS One. 2008 Jul 02;3(7):e2576
pubmed: 18596974
J Clin Med. 2021 Jan 03;10(1):
pubmed: 33401546
Health Commun. 2008 Nov;23(6):548-59
pubmed: 19089702
Cytokine. 2008 Sep;43(3):374-9
pubmed: 18701317
Genes Dev. 2018 Oct 1;32(19-20):1267-1284
pubmed: 30275043
Cancer Cell Microenviron. 2015;2(3):
pubmed: 26807429
Ochsner J. 2014 Winter;14(4):681-95
pubmed: 25598735
Oncology. 2009;77 Suppl 1:23-37
pubmed: 20130429
Oncol Rep. 2019 Dec;42(6):2499-2511
pubmed: 31578575
Adv Exp Med Biol. 2020;1240:59-72
pubmed: 32060888
Bioinformation. 2010 Oct 06;5(4):166-7
pubmed: 21364780
CA Cancer J Clin. 2020 Jan;70(1):7-30
pubmed: 31912902
Nature. 2012 Oct 4;490(7418):61-70
pubmed: 23000897
Cancer. 2002 Aug 1;95(3):663-7
pubmed: 12209760
BMC Cancer. 2016 Feb 19;16:127
pubmed: 26896000
Eur J Cancer. 2006 Apr;42(6):745-50
pubmed: 16517151
Mol Cancer Res. 2006 Apr;4(4):221-33
pubmed: 16603636
Am J Clin Hypn. 2010 Jul;53(1):27-46
pubmed: 20718241
Am J Clin Hypn. 2006 Apr;48(4):263-78
pubmed: 16696558
Mindfulness (N Y). 2018;9(3):673-692
pubmed: 29875880
Transl Med UniSa. 2018 Mar 31;17:40-44
pubmed: 30083522
Adv Integr Med. 2018 Apr;5(1):9-14
pubmed: 30271706
J Allergy Clin Immunol. 2010 Feb;125(2 Suppl 2):S53-72
pubmed: 19932918
Int J Clin Exp Pathol. 2014 Sep 15;7(10):6671-8
pubmed: 25400746
Brain Behav Immun. 2013 Mar;30 Suppl:S41-7
pubmed: 22790082
Immunol Lett. 2009 Sep 22;126(1-2):91-2
pubmed: 19699235
Am J Public Health. 2013 Oct;103 Suppl 1:S84-92
pubmed: 23927506
Int J Mol Sci. 2020 Jun 27;21(13):
pubmed: 32605126
J Psychosom Res. 2002 Feb;52(2):69-77
pubmed: 11832252
Int J Clin Exp Hypn. 2020 Jul-Sep;68(3):371-383
pubmed: 32543265
Int J Mol Sci. 2020 Sep 04;21(18):
pubmed: 32899866
Brain Behav. 2020 Jun;10(6):e01651
pubmed: 32383355
J Clin Invest. 2013 Dec;123(12):5269-83
pubmed: 24270418
Curr Med Chem. 2020;27(17):2826-2839
pubmed: 31804159
Curr Opin Genet Dev. 2008 Feb;18(1):3-10
pubmed: 18325755
World J Surg Oncol. 2020 Aug 7;18(1):197
pubmed: 32767977
Anticancer Res. 2019 Sep;39(9):5009-5018
pubmed: 31519608
Int J Oncol. 2019 Sep;55(3):684-696
pubmed: 31322183
Sci Rep. 2019 Mar 8;9(1):4014
pubmed: 30850664
Neoplasma. 2016;63(1):141-9
pubmed: 26639244
Cancer Cell. 2013 Aug 12;24(2):143-4
pubmed: 23948294
Am J Clin Hypn. 2009 Jan;51(3):281-98
pubmed: 19216213
J Pathol. 2014 Jan;232(2):199-209
pubmed: 24122236
Front Immunol. 2017 Jun 16;8:670
pubmed: 28670311
Evid Based Complement Alternat Med. 2017;2017:4365429
pubmed: 28316635
Neurosci Lett. 2005 Jun 10-17;381(1-2):57-62
pubmed: 15882790
Med Oncol. 2011 Dec;28 Suppl 1:S15-21
pubmed: 20725807
Cell Death Dis. 2018 Aug 29;9(9):880
pubmed: 30158589
Lancet. 2008 Mar 1;371(9614):771-83
pubmed: 18275997
J Cancer Res Ther. 2018 Jan-Mar;14(2):345-350
pubmed: 29516917
Int J Mol Sci. 2020 Sep 03;21(17):
pubmed: 32899139
Front Psychol. 2018 Jun 20;9:976
pubmed: 29973895
Am J Clin Hypn. 2011 Oct;54(2):133-52
pubmed: 22125895
Brain Behav Immun. 2019 Feb;76:97-103
pubmed: 30447280
Br J Cancer. 2012 Jul 10;107(2):287-90
pubmed: 22699823
BMC Cancer. 2019 Nov 12;19(1):1091
pubmed: 31718602
Brain Behav Immun. 2013 Mar;30 Suppl:S88-98
pubmed: 22627072
Oncotarget. 2014 Feb 15;5(3):788-801
pubmed: 24553191
Health Qual Life Outcomes. 2003 Aug 01;1:29
pubmed: 12914662
Lancet. 2017 Mar 18;389(10074):1134-1150
pubmed: 27865536
BMC Cancer. 2014 Oct 24;14:781
pubmed: 25344051
Psychoneuroendocrinology. 2020 Aug;118:104708
pubmed: 32474348
J Transl Med. 2012 Jan 03;10:1
pubmed: 22214470
Br J Psychiatry. 2002 Jan;180:51-60
pubmed: 11772852
Breast Cancer Res. 2005;7(4):R402-10
pubmed: 15987445
PLoS One. 2013 May 01;8(5):e62817
pubmed: 23650531
World J Gastroenterol. 2014 Jul 28;20(28):9261-9
pubmed: 25071319
Am J Clin Hypn. 2007 Apr;49(4):267-81
pubmed: 17444364
Breast. 2013 Aug;22 Suppl 2:S50-6
pubmed: 24074793
Biol Psychiatry. 2012 Feb 15;71(4):366-72
pubmed: 22088795
Epigenomics. 2013 Apr;5(2):177-94
pubmed: 23566095
Oncologist. 2009 Jul;14(7):645-56
pubmed: 19608638
Cancer. 2008 Dec 15;113(12):3450-8
pubmed: 19016270
Anticancer Res. 2017 Sep;37(9):4867-4871
pubmed: 28870907

Auteurs

Mauro Cozzolino (M)

Department of Human, Philosophical and Educational Sciences, University of Salerno, 84084 Fisciano (SA), Italy.

Stefania Cocco (S)

Department of Breast and Thoracic Oncology, Division of Breast Medical Oncology, Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale", 80131 Naples, Italy.

Michela Piezzo (M)

Department of Breast and Thoracic Oncology, Division of Breast Medical Oncology, Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale", 80131 Naples, Italy.

Giovanna Celia (G)

Department of Human, Philosophical and Educational Sciences, University of Salerno, 84084 Fisciano (SA), Italy.

Susan Costantini (S)

Experimental Pharmacology Unit-Mercogliano Laboratory, Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale", 80131 Naples, Italy.

Valentina Abate (V)

Psychology Unit, Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale", 80131 Naples, Italy.

Francesca Capone (F)

Experimental Pharmacology Unit-Mercogliano Laboratory, Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale", 80131 Naples, Italy.

Daniela Barberio (D)

Psychology Unit, Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale", 80131 Naples, Italy.

Laura Girelli (L)

Department of Human, Philosophical and Educational Sciences, University of Salerno, 84084 Fisciano (SA), Italy.

Elisa Cavicchiolo (E)

Department of Human, Philosophical and Educational Sciences, University of Salerno, 84084 Fisciano (SA), Italy.

Paolo Antonio Ascierto (PA)

Department Melanoma, Cancer Immunotherapy and Development Therapeutics, Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale", 80131 Naples, Italy.

Gabriele Madonna (G)

Department Melanoma, Cancer Immunotherapy and Development Therapeutics, Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale", 80131 Naples, Italy.

Alfredo Budillon (A)

Experimental Pharmacology Unit-Mercogliano Laboratory, Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale", 80131 Naples, Italy.

Michelino De Laurentiis (M)

Department of Breast and Thoracic Oncology, Division of Breast Medical Oncology, Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale", 80131 Naples, Italy.

Classifications MeSH